Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up

Acta Ophthalmologica

Volumn 93, Issue 8, 2015, Pages 745-752

  Peters, Dorothea ^a   Heijl, Anders ^a   Brenner, Lena ^b   Bengtsson, Boel ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Helsingborg Animal Hospital   (Sweden)

Author keywords

blindness; low vision; open angle glaucoma; vision related quality of life; visual impairment

Indexed keywords

ANTIGLAUCOMA AGENT;

ADULT; AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; BLINDNESS; FEMALE; FOLLOW UP; GLAUCOMA SURGERY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OPEN ANGLE GLAUCOMA; PERIMETRY; PRIORITY JOURNAL; PSEUDOEXFOLIATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASCH ANALYSIS; VERY ELDERLY; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; VISUAL THRESHOLD; CONTROLLED STUDY; INTRAOCULAR PRESSURE; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SICKNESS IMPACT PROFILE; VISUAL DISORDER;

AGED; AGED, 80 AND OVER; EXFOLIATION SYNDROME; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; SURVEYS AND QUESTIONNAIRES; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS; VISUALLY IMPAIRED PERSONS;

EID: 84955664526     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12839     Document Type: Article

References (39)

1. Andrich D, (1978): A rating scale formulation for ordered response categories. Psychometrika 43: 561-573.
2. Arora KS, Boland MV, Friedman DS, Jefferys JL, West SK, &, Ramulu PY, (2013): The relationship between better-eye and integrated visual field mean deviation and visual disability. Ophthalmology 120: 2476-2484.
3. Asaoka R, Crabb DP, Yamashita T, Russell RA, Wang YX, &, Garway-Heath DF, (2011): Patients have two eyes!: binocular versus better eye visual field indices. Invest Ophthalmol Vis Sci 52: 7007-7011.
4. Broman AT, Quigley HA, West SK, et al., (2008): Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci 49: 66-76.
5. Coleman AL, (2007): Sources of binocular suprathreshold visual field loss in a cohort of older women being followed for risk of falls (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 105: 312-329.
6. Dougherty BE, &, Bullimore MA, (2010): Comparison of scoring approaches for the NEI VFQ-25 in low vision. Optom Vis Sci 87: 543-548.
7. van Gestel A, Webers CAB, Beckers HJM, van Dongen M, Severens JL, Hendrikse F, &, Schouten J, (2010): The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye 24: 1759-1769.
8. Gutierrez P, Wilson MR, Johnson C, et al., (1997): Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 115: 777-784.
9. Heijl A, Leske MC, Bengtsson B, Hyman L, &, Hussein M, (2002): Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120: 1268-1279.
10. Hyman LG, Komaroff E, Heijl A, Bengtsson B, &, Leske MC, (2005): Treatment and vision-related quality of life in the early manifest glaucoma trial. Ophthalmology 112: 1505-1513.
11. Kulkarni KM, Mayer JR, Lorenzana LL, Myers JS, &, Spaeth GL, (2012): Visual field staging systems in glaucoma and the activities of daily living. Am J Ophthalmol 154: 445-451 e443.
12. Leske MC, Heijl A, Hyman L, &, Bengtsson B, (1999): Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106: 2144-2153.
13. Lisboa R, Chun YS, Zangwill LM, Weinreb RN, Rosen PN, Liebmann JM, Girkin CA, &, Medeiros FA, (2013): Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma. JAMA Ophthalmol 131: 486-494.
14. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, &, Hays RD, (2001): Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 119: 1050-1058.
15. Marella M, Pesudovs K, Keeffe JE, O'Connor PM, Rees G, &, Lamoureux EL, (2010): The psychometric validity of the NEI VFQ-25 for use in a low-vision population. Invest Ophthalmol Vis Sci 51: 2878-2884.
16. Massof RW, (2002): The measurement of vision disability. Optom Vis Sci 79: 516-552.
17. Massof RW, (2007): An interval-scaled scoring algorithm for visual function questionnaires. Optom Vis Sci 84: 689-704.
18. Massof RW, (2011): Understanding Rasch and item response theory models: applications to the estimation and validation of interval latent trait measures from responses to rating scale questionnaires. Ophthalmic Epidemiol 18: 1-19.
19. Massof RW, &, Fletcher DC, (2001): Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Res 41: 397-413.
20. McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R, & Los Angeles Latino Eye Study Group (2008): Impact of visual field loss on health-related quality of life in glaucoma-The Los Angeles Latino Eye Study. Ophthalmology 115: 941-948.
21. Medeiros FA, Gracitelli CP, Boer ER, Weinreb RN, Zangwill LM, &, Rosen PN, (2015): Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients. Ophthalmology 122: 293-301.
22. Mills RP, Janz NK, Wren PA, Guire KE, & Cigts Study Grp (2001): Correlation of visual field with quality-of-life measures at diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS). J Glaucoma 10: 192-198.
23. Murata H, Hirasawa H, Aoyama Y, Sugisaki K, Araie M, Mayama C, Aihara M, &, Asaoka R, (2013): Identifying areas of the visual field important for quality of life in patients with glaucoma. PLoS ONE 8: e58695.
24. Musch DC, Gillespie BW, Niziol LM, Janz NK, Wren PA, Rockwood EJ, Lichter PR, & Collaborative Initial Glaucoma Treatment Study G (2006): Cataract extraction in the collaborative initial glaucoma treatment study: incidence, risk factors, and the effect of cataract progression and extraction on clinical and quality-of-life outcomes. Arch Ophthalmol 124: 1694-1700.
25. Nassiri N, Mehravaran S, Nouri-Mahdavi K, &, Coleman AL, (2013): National Eye Institute Visual Function Questionnaire: usefulness in glaucoma. Optom Vis Sci 90: 745-753.
26. Okamoto M, Sugisaki K, Murata H, Hirasawa H, Mayama C, &, Asaoka R, (2014): Impact of better and worse eye damage on quality of life in advanced glaucoma. Sci Rep 4: 4144.
27. Parrish RK, Gedde SJ, Scott IU, Feuer WJ, Schiffman JC, Mangione CM, &, MontenegroPiniella A, (1997): Visual function and quality of life among patients with glaucoma. Arch Ophthalmol 115: 1447-1455.
28. Pesudovs K, Burr JM, Harley C, &, Elliott DB, (2007): The development, assessment, and selection of questionnaires. Optom Vis Sci 84: 663-674.
29. Pesudovs K, Gothwal VK, Wright T, &, Lamoureux EL, (2010): Remediating serious flaws in the National Eye Institute Visual Function Questionnaire. J Cataract Refract Surg 36: 718-732.
30. Peters D, Bengtsson B, &, Heijl A, (2013): Lifetime risk of blindness in open-angle glaucoma. Am J Ophthalmol 156: 724-730.
31. Quigley HA, &, Vitale S, (1997): Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci 38: 83-91.
32. Ramulu P, (2009): Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol 20: 92-98.
33. Saunders LJ, Russell RA, &, Crabb DP, (2012): Practical landmarks for visual field disability in glaucoma. Br J Ophthalmol 96: 1185-1189.
34. Sawada H, Fukuchi T, &, Abe H, (2011): Evaluation of the relationship between quality of vision and the visual function index in Japanese glaucoma patients. Graefes Arch Clin Exp Ophthalmol 249: 1721-1727.
35. Smith EV Jr, (2002): Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 3: 205-231.
36. Sumi I, Shirato S, Matsumoto S, &, Araie M, (2003): The relationship between visual disability and visual field in patients with glaucoma. Ophthalmology 110: 332-339.
37. Tabrett DR, &, Latham K, (2012): Important areas of the central binocular visual field for daily functioning in the visually impaired. Ophthalmic Physiol Opt 32: 156-163.
38. Varma R, Wu J, Chong K, Azen SP, &, Hays RD, (2006): Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 113: 1846-1853.
39. Wright B, &, Linacre J, (1994): Reasonable mean-square fit values. Rasch Meas Trans 8: 370. Available at: http://www.rasch.org/rmt/rmt83b.htm (accessed 8 May 2015).